Jiangsu Nhwa Pharmaceutical Management
Management criteria checks 3/4
Jiangsu Nhwa Pharmaceutical's CEO is Jiaquan Sun, appointed in May 2013, has a tenure of 11.58 years. directly owns 0.07% of the company’s shares, worth CN¥17.88M. The average tenure of the management team and the board of directors is 11.6 years and 17.7 years respectively.
Key information
Jiaquan Sun
Chief executive officer
CN¥4.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.6yrs |
| CEO ownership | 0.07% |
| Management average tenure | 11.6yrs |
| Board average tenure | 17.7yrs |
Recent management updates
Recent updates
Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE:002262) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Oct 28
Is Now The Time To Put Jiangsu Nhwa Pharmaceutical (SZSE:002262) On Your Watchlist?
Oct 21Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has A Rock Solid Balance Sheet
Sep 20The Market Doesn't Like What It Sees From Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Earnings Yet
Sep 04Here's Why Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has Caught The Eye Of Investors
Jul 22Jiangsu Nhwa Pharmaceutical (SZSE:002262) Seems To Use Debt Rather Sparingly
Jun 16Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Share Price Is Matching Sentiment Around Its Earnings
May 09Jiangsu Nhwa Pharmaceutical (SZSE:002262) Ticks All The Boxes When It Comes To Earnings Growth
Apr 18Earnings Update: Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE:002262) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Apr 02CEO
Jiaquan Sun (48 yo)
11.6yrs
Tenure
CN¥4,800,000
Compensation
Mr. Jiaquan Sun has been General Manager at Jiangsu Nhwa Pharmaceutical Co., Ltd. since May 31, 2013 and has been its Non-Independent Director since April 1, 2019. Mr. Sun serves as General Manager of Jian...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 11.6yrs | CN¥4.80m | 0.070% CN¥ 17.9m | |
| Chief Financial Officer | 2.2yrs | CN¥633.60k | no data | |
| Deputy GM & Non-Independent Director | 11.6yrs | CN¥200.00k | 3.93% CN¥ 1.0b | |
| Deputy GM & Non-Independent Director | 11.6yrs | CN¥200.00k | 3.93% CN¥ 1.0b | |
| Deputy GM & Non-Independent Director | 11.6yrs | CN¥200.00k | 3.69% CN¥ 943.9m | |
| Deputy GM & Secretary | 11.6yrs | CN¥413.70k | 0.0053% CN¥ 1.4m |
11.6yrs
Average Tenure
59yo
Average Age
Experienced Management: 002262's management team is seasoned and experienced (11.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 14.6yrs | CN¥4.80m | 0.070% CN¥ 17.9m | |
| Deputy GM & Non-Independent Director | 17.7yrs | CN¥200.00k | 3.93% CN¥ 1.0b | |
| Deputy GM & Non-Independent Director | 17.7yrs | CN¥200.00k | 3.93% CN¥ 1.0b | |
| Deputy GM & Non-Independent Director | 17.7yrs | CN¥200.00k | 3.69% CN¥ 943.9m | |
| Non-Independent Chairman of the Board | 17.7yrs | CN¥250.00k | 4.87% CN¥ 1.2b | |
| Independent Director | 5.8yrs | CN¥50.00k | no data | |
| Independent Director | 2.7yrs | CN¥50.00k | no data | |
| Chairman of the Supervisory Board | 17.7yrs | no data | no data | |
| Member of the Supervisory Board | 17.7yrs | no data | no data | |
| Employee Representative Member of Supervisory Board | 17.7yrs | no data | no data | |
| Independent Director | 2.7yrs | CN¥50.00k | no data | |
| Independent Director | 2.7yrs | CN¥50.00k | no data |
17.7yrs
Average Tenure
61yo
Average Age
Experienced Board: 002262's board of directors are seasoned and experienced ( 17.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 07:32 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Nhwa Pharmaceutical Co., LTD is covered by 24 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Yanyin Zhu | China International Capital Corporation Limited |
| Shanshan Li | China Merchants Securities Co. Ltd. |